Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression Yahoo Eurosport UK
Avoid routine daily use of fluoxetine for depression after stroke, recommends JAMA study Medical Dialogues
Paranoia vs. anxiety: Symptoms, causes, and more Medical News Today
VistaGen Therapeutics Further GuruFocus.com
VistaGen Therapeutics Further Advances PALISADE Phase 3 Program for PH94B in Social Anxiety ... KULR-TV
STUDENT VOICE: Mental health is an important issue for student parents The Hechinger Report
Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial Business Wire
Human Gut Bacteria Could Be Accumulating Our Medications Without Us Realizing ScienceAlert
Could ketamine be a cure for some mental health problems? Channel 4 News
Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy? The Guardian
